Memantine
An N-methyl-D-aspartate (NMDA) receptor antagonist.
General information
Memantine is a drug approved for Alzheimer’s disease treatment. It acts as a N-methyl-D-aspartate (NMDA) receptor antagonist, by which it blocks the effects of glutamate (DrugBank).
Memantine on PubChem
Memantine on Wikipedia
Marketed as
MEMANTINE HYDROCHLORIDE; NAMENDA (MEMANTINE HYDROCHLORIDE)
CC12CC3CC(C1)(CC(C3)(C2)N)C
Supporting references
Link | Tested on | Impact factor | Notes | Publication date |
---|---|---|---|---|
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine
Envelope protein Small molecule In vitro |
In vitro ion channel assay | 2.99 | Blocks the SARS-CoV-2 E protein ion channel in vitro. |
Jun/20/2020 |